LANSING (AP) State agencies and patients in Michigan could get several million dollars from a settlement with a generic drug maker that was accused of price-fixing, Attorney General Jennifer Granholm said yesterday.
The Federal Trade Commission and attorneys general in all 50 states accused Pittsburgh-based Mylan Laboratories of orchestrating an illegal, 2,000 percent price increase for the drugs lorazepam and clorazepate.
As part of a settlement with the FTC reached late last year, Mylan will distribute $100 million nationally to state Medicaid agencies and patients. Granholm agreed to that settlement yesterday.
Mylan spokeswoman Patricia Sunseri was unavailable for comment yesterday.
Granholm spokesman Chris De Witt said the state doesn”t yet know its share of the $100 million settlement. But Granholm has estimated that nearly one million people in Michigan use lorazepam and clorazepate.
Lorazepam is used to treat anxiety, tension and insomnia and is often prescribed for nursing home patients and those with cancer and AIDS. Clorazepate is used to treat anxiety and hypertension.
Mylan was accused of increasing the cost of a 500-count bottle of lorazepam from $7.30 to $191.50. Bottles of 500 clorazepate were increased from $11.36 to $377, Granholm said.